A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis
Abstract Amyotrophic lateral sclerosis (ALS) is the most common fatal motor neuron disease in adults. Numerous studies indicate that ALS is a systemic disease that affects whole body physiology and metabolic homeostasis. Using a mouse model of the disease (SOD1G86R), we investigated muscle physiolog...
Main Authors: | Lavinia Palamiuc, Anna Schlagowski, Shyuan T Ngo, Aurelia Vernay, Sylvie Dirrig‐Grosch, Alexandre Henriques, Anne‐Laurence Boutillier, Joffrey Zoll, Andoni Echaniz‐Laguna, Jean‐Philippe Loeffler, Frédérique René |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2015-05-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201404433 |
Similar Items
-
Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
by: Siobhan E. Kirk, et al.
Published: (2019-03-01) -
Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis
by: Leanne Jiang, et al.
Published: (2022-07-01) -
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
by: Tesfaye Wolde Tefera, et al.
Published: (2021-01-01) -
Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis
by: Alexandre Henriques, et al.
Published: (2018-01-01) -
Depression in amyotrophic lateral sclerosis
by: Joanna Iłżecka
Published: (2021-10-01)